MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $185.12 million. The enterprise value is $243.49 million.
Important Dates
The next confirmed earnings date is Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 49.50 million shares outstanding. The number of shares has increased by 80.01% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +80.01% |
| Shares Change (QoQ) | -3.77% |
| Owned by Insiders (%) | 7.62% |
| Owned by Institutions (%) | 26.28% |
| Float | 33.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 1.42 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.14
| Current Ratio | 1.14 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.13 |
Financial Efficiency
Return on equity (ROE) is -720.01% and return on invested capital (ROIC) is -11.31%.
| Return on Equity (ROE) | -720.01% |
| Return on Assets (ROA) | -5.52% |
| Return on Invested Capital (ROIC) | -11.31% |
| Return on Capital Employed (ROCE) | -13.34% |
| Weighted Average Cost of Capital (WACC) | -2,089,955.97% |
| Revenue Per Employee | $330,349 |
| Profits Per Employee | -$100,744 |
| Employee Count | 312 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 7.00 |
Taxes
| Income Tax | -237,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.50% in the last 52 weeks. The beta is -558,053.96, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -558,053.96 |
| 52-Week Price Change | +85.50% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 52.90 |
| Average Volume (20 Days) | 154,218 |
Short Selling Information
| Short Interest | 39,441 |
| Short Previous Month | 15,027 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, MDxHealth had revenue of $103.07 million and -$31.43 million in losses. Loss per share was -$0.64.
| Revenue | 103.07M |
| Gross Profit | 66.46M |
| Operating Income | -13.75M |
| Pretax Income | -31.67M |
| Net Income | -31.43M |
| EBITDA | -7.07M |
| EBIT | -13.75M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $32.01 million in cash and $87.91 million in debt, with a net cash position of -$55.89 million or -$1.13 per share.
| Cash & Cash Equivalents | 32.01M |
| Total Debt | 87.91M |
| Net Cash | -55.89M |
| Net Cash Per Share | -$1.13 |
| Equity (Book Value) | -8.26M |
| Book Value Per Share | -0.17 |
| Working Capital | 7.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.69 million and capital expenditures -$1.30 million, giving a free cash flow of -$6.98 million.
| Operating Cash Flow | -5.69M |
| Capital Expenditures | -1.30M |
| Free Cash Flow | -6.98M |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is 64.48%, with operating and profit margins of -13.34% and -30.50%.
| Gross Margin | 64.48% |
| Operating Margin | -13.34% |
| Pretax Margin | -30.73% |
| Profit Margin | -30.50% |
| EBITDA Margin | -6.86% |
| EBIT Margin | -13.34% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.01% |
| Shareholder Yield | -80.01% |
| Earnings Yield | -16.76% |
| FCF Yield | -3.72% |
Analyst Forecast
The average price target for MDxHealth is $7.67, which is 105.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.67 |
| Price Target Difference | 105.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 21.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -2.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.75 |
| Piotroski F-Score | 3 |
